United Therapeutics reported $31.5M in Interest Income for its fiscal quarter ending in June of 2026.





Interest Income Change Date
Amarin USD 3.37M 3.37M Dec/2024
Baxter International USD 13M 1000K Jun/2026
Bayer EUR 169M 39M Dec/2025
BioCryst Pharmaceuticals USD -0.13 3.59M Dec/2024
Biogen USD 25.3M 12.6M Jun/2026
BioMarin Pharmaceutical USD 4.63M 5.85M Sep/2026
Gilead Sciences USD 45M 50M Jun/2026
GlaxoSmithKline GBP 58M 36M Jun/2026
Insmed USD 765K 55K Sep/2024
Ionis Pharmaceuticals USD -0.66 0.29 Dec/2024
J&J USD 0.09 2.18 Sep/2026
Moderna USD 67M 5M Jun/2026
Pfizer USD 0.56 0.6 Sep/2026
Regeneron Pharmaceuticals USD 183.3M 200K Jun/2026
Sarepta Therapeutics USD 7.16M 160K Jun/2026
United Therapeutics USD 31.5M 10.3M Jun/2026
Vertex Pharmaceuticals USD 118.4M 2.2M Sep/2026